Clinical trial
Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With…
NCT00321412 · Ocera Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00321412 |
|---|---|
| Title | Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas |
| Official title | A Double-blind, Randomized, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Mild to Moderately Active Crohn's Patients With Fistulas |
| Lead sponsor | Ocera Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease, Intestinal Fistula |
| Intervention type | Drug |
| Interventions | AST-120 |
| Enrollment | 191 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | May 3, 2006 |
| Last update posted | May 30, 2014 |
| Countries | Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Netherlands, Poland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: